Risk of exacerbation soon after discontinuing clozapine maintenance treatment of chronic psychotic illness evidently is high, though its quantification requires further study- Pharmacodynamic contributions to this response are probably complex, and any single mechanism, dopaminergic or serotonergic, is likely to be incomplete. Dr Meltzer's anecdotal observation of no early relapses in 4 of 4 patients switched from clozapine therapy to the typical neuroleptic perphenazine plus serotonin antagonist cyproheptadine is interesting and may support his thesis that antiserotonergic actions of clozapine are particularly important.2 It also encourages systematic studies with selective antiserotonin agents.He also noted that risperidone protected against relapses after stopping clozapine therapy, although details were not provided, and suggested that its potent antiserotonin properties may account for this response, and lack of D4 dopamine receptor selectivity, preclude involvement of dopaminergic mechanisms.2 This neuroleptic drug has very high serotonin2 (5-hydroxytryptamine2 [5-HT2] affinity (affinity
Baldessarini RJ, Tarazi FI, Kula NS, Gardner DM. Clozapine Withdrawal: Serotonergic or Dopaminergic Mechanisms?-Reply. Arch Gen Psychiatry. 1997;54(8):761–762. doi:10.1001/archpsyc.1997.01830200095014
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.